Study identifies a new way brain cells die in Alzheimer's disease

(Medical Xpress) -- A new study challenges conventional thinking about how brain cells die in Alzheimer’s disease. The findings demonstrate a previously unknown mechanism by which the cells die and will help lead researchers in new directions for treating the degenerative brain disease. The study by scientists at the University of Calgary’s Hotchkiss Brain Institute is published this week in the prestigious journal Proceedings of the National Academy of Sciences (PNAS).

At the cellular level, our brains require a delicate balance of chemicals and molecules in order to function properly. The cells ‘talk to each other’ using chemicals called neurotransmitters, which activate specialized . But as this study by Gerald Zamponi, PhD, and Dr. Peter Stys shows, the cells of Alzheimer’s patients are dying because the key receptor responsible for memory and learning, called the NMDA receptor, is malfunctioning.

It has previously been shown that Alzheimer’s patients have a malformed protein called Ab42 present in their brains. With this research, Stys, Professor in the Department of Clinical Neurosciences and Zamponi, Head of the Department of Physiology and Pharmacology, show in animal models a completely new mechanism of how this protein kills brain cells.

They found that the NMDA receptor is strongly regulated by . If copper is prevented from regulating this key receptor, such as in Alzheimer’s disease, brain cells become over stimulated; with time they become sick and ultimately die.

“We cannot underestimate the importance of copper for proper brain cell functioning,” says Zamponi, “For example, there are several diseases where copper levels are altered, and this leads to the same NMDA receptor deficiency and neurodegeneration."

When the Ab42 steals the copper away from the NMDA receptor, the receptor gets over-activated, which kills the brain cell. “This particular mechanism was previously unknown and could have fundamentally important therapeutic implications,” says Zamponi.

Co-senior author Stys adds, “Ultimately we are seeing an underlying deficiency in copper, but at a subcellular level. Unfortunately because of the way that the body regulates copper, we can’t simply eat more of a certain kind of food or take a copper supplement to compensate. What we are looking at now is the development of a drug that acts on the NMDA receptor to mimic the effect of copper in the brain, therefore restoring normal NMDA receptor function and protecting brain cells.”

Alzheimer’s disease destroys and results in memory loss, changes in mood and behavior and difficulty with day-to-day tasks. Most commonly diagnosed in adults over the age of 65, more than 100,000 new cases of this progressive and eventually fatal disease are diagnosed each year.

Bill Gaudette, CEO, Alzheimer Society of Alberta & Northwest Territories, noted, “Our Society, and the people we work with, welcome the research being conducted by Drs. Zamponi and Stys at the Hotchkiss Institute. The promising therapeutic implications of this work could potentially be a ‘game changer’ for everyone involved with dementia research and care.”

Related Stories

New drug target for Alzheimer's, stroke discovered

Oct 11, 2011

A tiny piece of a critical receptor that fuels the brain and without which sentient beings cannot live has been discovered by University at Buffalo scientists as a promising new drug target for Alzheimer's and other neurodegenerative ...

Falls may be early sign of Alzheimer's

Jul 18, 2011

Falls and balance problems may be early indicators of Alzheimer’s disease, researchers at Washington University School of Medicine in St. Louis report July 17, 2011, at the Alzheimer’s Association International ...

Recommended for you

Leeches help save woman's ear after pit bull mauling

7 hours ago

(HealthDay)—A pit bull attack in July 2013 left a 19-year-old woman with her left ear ripped from her head, leaving an open wound. After preserving the ear, the surgical team started with a reconnection ...

New pain relief targets discovered

19 hours ago

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching ...

Building 'smart' cell-based therapies

20 hours ago

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

ArtflDgr
1 / 5 (1) Jan 20, 2012
At the cellular level, our brains require a delicate balance of chemicals and molecules in order to function properly

yes... so delicate that if you randomly change it, rather than get collapse and failure, you get cancer

so delicate that you can add an extra chromosome by accident and it all works...

anyone other than me notice that we keep acting as if there is this super delicate fragile everything in nature as if a god created it and we have to be careful not to break it?

the environment is so delicate..
which is why life survived astaroid events spanning over 100 kilometers... and why life has been here for a few billion years... so delicate..

the newtonian idea of a perfect universe tick tocking along in fragility that can be upset by any external something (when there is no external anything), is a erroneous view